$2.50
0[0.00%]
At close: May 1
$2.50
0[0.00%]
After Hours: 4:59PM EDT
OncoCyte
(NASDAQ:OCX)OncoCyte Stock (NASDAQ:OCX), Earnings Estimates, EPS, and Revenue
OncoCyte reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 13
EPS Estimate
$-0.760
Quarterly Revenue Estimate
$250K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$1.5M
Analyze the earnings history of OncoCyte using advanced sorting and filters.
No data available to display
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|
FAQ
When is OncoCyte (NASDAQ:OCX) reporting earnings?
OncoCyte (OCX) is scheduled to report earnings on May 13, 2024. The last reported earnings were for reported on April 12, 2024 for Q4.
What were the latest earnings per share (EPS) for OncoCyte (NASDAQ:OCX)?
The Actual EPS was $-2.18, which missed the estimate of $-1.14.
What were OncoCyte’s (NASDAQ:OCX) revenues?
The Actual Revenue was $314K, which missed the estimate of $320K.
Browse earnings estimates, EPS, and revenue on all stocks.